UMich Rogel receives $11.1M SPORE for radiosensitization research

The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop

In 1998, lung cancer was the leading cause of cancer deaths in the United States, with 160,000 deaths per year. That statistic inspired Matthew Meyerson, who would soon start working at the Dana-Farber Cancer Institute, to specialize in lung cancer.

July 05, 2024

Vol.50 No.27

Clinical Roundup

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

The American Society for Radiation Oncology published an updated clinical guideline in Practical Radiation Oncology that details best practices for using radiation therapy to treat patients who have oropharyngeal squamous cell carcinoma caused by the human papilloma virus.

June 21, 2024

Vol.50 No.25

Clinical Roundup

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

Cosylab, a provider of control systems and software solutions for complex and precise machines, has entered into a collaboration with Mayo Clinic to advance cancer care in the United States and beyond.

June 14, 2024

Vol.50 No.24

Clinical Roundup

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

Researchers at MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer radiation before mastectomy allowed for concurrent breast reconstruction surgery, which reduced the number of operations required, minimized treatment delays, and improved patient satisfaction.

April 12, 2024

Vol.50 No.15

Clinical Roundup

UCLA study: High-dose radiotherapy + chemo effective in treating NSCLC

A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center showed that using high doses of radiation while integrating an ablative radiotherapy technique called stereotactic ablative radiotherapy concurrently with chemotherapy is safe and effective in treating people with locally advanced non-small cell lung cancer that is not suitable for surgery.

January 19, 2024

Vol.50 No.03

In Brief

Kristin Heath named executive director of the UF Health Proton Therapy Institute

Kristin A. Heath was named executive director of the University of Florida Health Proton Therapy Institute. Kristin A. Heath succeeds Stuart L. Klein, who retired in November 2023 after 18 years.

January 05, 2024

Vol.50 No.01

UMich Rogel receives $11.1M SPORE for radiosensitization research

YOU MAY BE INTERESTED IN

The early days of EGFR: Herbst, Haber, Meyerson, Pao, Sequist present at Yale SPORE workshop

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

UCLA study: High-dose radiotherapy + chemo effective in treating NSCLC

Kristin Heath named executive director of the UF Health Proton Therapy Institute

Renew today!

Subscriber content

Login